Cite
HARVARD Citation
Ribaldone, D. et al. (2017). Efficacy of infliximab biosimilars in patients with Crohn's disease. Lancet. 390 (10111), pp. 2435-2436. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ribaldone, D. et al. (2017). Efficacy of infliximab biosimilars in patients with Crohn's disease. Lancet. 390 (10111), pp. 2435-2436. [Online].